# An Open Label Multi-Dose Study to Examine the Effect of Coated Nifedipine Suppository on Anal Fissure Pain and Healing

> **NCT02023047** · PHASE1,PHASE2 · TERMINATED · sponsor: **RDD Pharma Ltd** · enrollment: 33 (actual)

## Conditions studied

- Anal Fissure

## Interventions

- **DRUG:** Nifedipine 12 mg coated suppositories

## Key facts

- **NCT ID:** NCT02023047
- **Lead sponsor:** RDD Pharma Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-03
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 33 (ACTUAL)
- **Why stopped:** Met primary endpoint
- **Last updated:** 2015-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02023047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02023047, "An Open Label Multi-Dose Study to Examine the Effect of Coated Nifedipine Suppository on Anal Fissure Pain and Healing". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02023047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*